300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Other Events
Financial Results, Press Release
Costs of Shutting Down or Selling Parts of the Business
Enters Into $2 Billion Accelerated Share Repurchase Agreement
Announces strategic investment in LLC
Stockholders Approve Charter Amendments at 2026 Annual Meeting
Announces results for first quarter 2026
.2CHAMPION-AF study of the WATCHMAN FLX™ Left Atrial Appendage Closure Device as a first-line therapy for stroke risk reduction meets all primary and secondary safety and efficacy endpoints
Q2
Q1
FY 2024
Q3
FY 2023
Registration Statement for Securities to be Offered to Employees
Prospectus Filed Pursuant to Rule 425
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(3)
S-4/A
S-4
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Amended Schedule 13G - Ownership Report
Specialized Disclosure Report
Correspondence
Submission Upload
Free Writing Prospectus